Login to Your Account

Abingworth closes $105M fund for clinical co-development work

By Cormac Sheridan
Staff Writer

Thursday, January 21, 2016

DUBLIN – Abingworth has raised $105 million for its first dedicated clinical co-development fund, which will extend its focus on putting up cash to help big pharma progress its pipeline without damaging its all-important P&L line.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription